Morning Breakouts

Latest KFF Health News Stories

‘You Cannot Put A Price On Your Child’s Life’: Families Push Back On Criticism Over $2.1M Drug

Morning Briefing

Once the FDA approved the treatment of the world’s priciest drug, the conversation over the cost of “miracle” treatments reignited. But for those who will benefit, there is no debate. In other pharmaceutical news: a look at this year’s big bioconference, President Donald Trump’s drug pricing agenda, CVS’ defense of its Aetna deal, and more.

‘Technology Isn’t The Problem. We’re The Problem.’: Teens’ Underlying Issues Need To Be Understood, Researchers Say

Morning Briefing

While it’s tempting to blame social media and gaming for mental health problems among teens, that is a mistake, says Dr. Michael Rich, an associate professor of pediatrics at Harvard Medical School. “What we need to do is look at the whole picture around these young people; we need to look at how kids and how we all are using social media,” he said. Other news on technology looks at a debate over the term “screen time” and pornography on YouTube.

New Drugs Substantially Improving Outcomes For People With Hard-To-Treat Forms Of Cancer

Morning Briefing

Experts say there have been some “wonderful” strides made in drugs to help those battling previously hard-to-treat cancers. But, they say, cost and side effects remain an issue. In other public health news: liquid biopsies, vaccines, doctor burn out, hunger, protection against mosquitoes, and more.

Generation O: The Kids Growing Up In Families That Are Ravaged By The Opioid Crisis

Morning Briefing

“My biggest fear is I’m going to get home and she’ll be dead,” said Cadence Nance, 12, of her mother. Across a country held in the grips of an opioid crisis, chaos, trauma and grief is the norm for children whose parents are addicted to the drugs. In other news on the crisis: painkillers for new moms, Johnson & Johnson’s track record of weathering trouble, an upcoming lawsuit, and more.

Both Sides Of CBD Debate Present Arguments In Front Of A Skeptical FDA Under Pressure To Regulate Booming Industry

Morning Briefing

Acting Commissioner Ned Sharpless launched the agency’s first hearing on CBD products Friday with a laundry of list of questions about cannabidiol. During the 10 hours of testimony that followed, hemp growers, start-up businesses, academic researchers and consumer advocates argued about how FDA should regulate the already booming CBD industry.

With More Flexibility, States Can Become More Nimble In Operating Medicaid Program, CMS Chief Says

Morning Briefing

CMS Administrator talks with CQ about the ways she wants to grant states more flexibility in operating their Medicaid programs. “I like to think about the future in Medicaid where we can say if this is the amount of money we have, these are the flexibilities, and we’re going to hold you accountable for health outcomes,” she said. “If we move to that different type of paradigm, we may see better results from the program in terms of the growth of the program, the costs of the program, and the quality of the program.” Medicaid news comes out of Utah, Illinois and Iowa, as well.

Health Law’s Medicaid Expansion Helped States Reduce Racial Disparities In Cancer Treatments

Morning Briefing

Before the health law went into effect, African Americans with advanced cancer were 4.8 percentage points less likely to start treatment for their disease within 30 days of being given a diagnosis. But today, black adults in states that expanded Medicaid have almost entirely caught up with white patients in getting timely treatment, researchers said.

Records Indicate Abuse Complaints Rarely Result In Discipline For Workers Caring For Migrant Kids

Morning Briefing

There have been hundreds of allegations of abuse or mistreatment, yet only one Department of Homeland Security employee was disciplined. A federal judge found the records disturbing and ordered the names of the accused agents made public. The government is trying to fight the decision.

Gillibrand’s Plan To Protect LGBTQ Community Includes Requirement That Insurers Cover Hormone Therapy

Morning Briefing

2020 hopeful Sen. Kirsten Gillibrand (D-N.Y.) unveiled the plan at the start of Pride Month. Meanwhile, President Donald Trump receives blowback for his administration’s attempts to chip away at protections for transgender patients.

‘Your Heart Hurts Every Time A New Tragedy Happens’: Virginia Beach Gunman Kills 12 In Shooting Rampage

Morning Briefing

Eleven of the victims were city employees, with tenures ranging from 11 months to more than 40 years. Many worked in the Public Utilities Department, the same department where the suspected shooter had worked as an engineer for about 15 years, according to police. The country’s latest mass shooting sends waves of grief through the network of survivors who have lived through similar crimes.

Judge Grants Missouri’s Last Remaining Abortion Clinic A Reprieve For Now

Morning Briefing

A stand-off between the St. Louis Planned Parenthood clinic and the state’s health department would have led to the closure of the facility on Friday had the court not intervened. U.S. St. Louis Circuit Judge Michael Stelzer granted Planned Parenthood a temporary restraining order, saying the group demonstrated immediate harm would occur if its license was allowed to expire. A hearing on the temporary injunction is set for Tuesday.

Health Care Could Woo A Lot Of Single-Issue Voters, But Have Candidates Found The Right Solutions Yet To Do So?

Morning Briefing

Americans are fed up with rising health care costs and are ready to vote about it. But candidates pushing for a massive overhaul may alienate some voters who are happy with their insurance. It’s going to be a fine line to walk for the 2020 candidates. Meanwhile, The Washington Post Fact Checker looks at potential “Medicare for All” savings.